Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
Research Animal Management Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
Int J Mol Sci. 2022 May 3;23(9):5082. doi: 10.3390/ijms23095082.
Complex asparagine-linked glycosylation plays key roles in cellular functions, including cellular signaling, protein stability, and immune response. Previously, we characterized the appearance of a complex asparagine-linked glycosylated form of lysosome-associated membrane protein 1 (LAMP1) in the cerebellum of mice. This LAMP1 form was found on activated microglia, and its appearance correlated both spatially and temporally with cerebellar Purkinje neuron loss. To test the importance of complex asparagine-linked glycosylation in NPC1 pathology, we generated NPC1 knock-out mice deficient in MGAT5, a key Golgi-resident glycosyl transferase involved in complex asparagine-linked glycosylation. Our results show that mice were smaller than mice, and exhibited earlier NPC1 disease onset and reduced lifespan. Western blot and lectin binding analyses of cerebellar extracts confirmed the reduction in complex asparagine-linked glycosylation, and the absence of the hyper-glycosylated LAMP1 previously observed. Western blot analysis of cerebellar extracts demonstrated reduced calbindin staining in mice compared to mutant mice, and immunofluorescent staining of cerebellar sections indicated decreased levels of Purkinje neurons and increased astrogliosis in mice. Our results suggest that reduced asparagine-linked glycosylation increases NPC1 disease severity in mice, and leads to the hypothesis that mutations in genes involved in asparagine-linked glycosylation may contribute to disease severity progression in individuals with NPC1. To examine this with respect to we analyzed 111 NPC1 patients for two SNPs associated with multiple sclerosis; however, we did not identify an association with NPC1 phenotypic severity.
复杂的天冬酰胺连接的糖基化在细胞功能中起着关键作用,包括细胞信号转导、蛋白质稳定性和免疫反应。此前,我们在 小鼠的小脑内鉴定出溶酶体相关膜蛋白 1(LAMP1)的一种复杂天冬酰胺连接的糖基化形式。这种 LAMP1 形式存在于激活的小胶质细胞上,其出现与小脑浦肯野神经元的丢失在空间和时间上相关。为了测试 NPC1 病理学中天冬酰胺连接的糖基化的重要性,我们生成了缺乏 MGAT5 的 NPC1 敲除小鼠,MGAT5 是一种参与复杂天冬酰胺连接的糖基化的关键高尔基体驻留糖基转移酶。我们的结果表明, 小鼠比 小鼠小,并且表现出更早的 NPC1 疾病发作和寿命缩短。小脑提取物的 Western blot 和凝集素结合分析证实了复杂天冬酰胺连接的糖基化减少,并且之前观察到的高糖基化 LAMP1 缺失。小脑提取物的 Western blot 分析表明,与 突变小鼠相比, 小鼠中的钙结合蛋白染色减少,小脑切片的免疫荧光染色表明 小鼠中的浦肯野神经元水平降低,星形胶质细胞增生增加。我们的结果表明,天冬酰胺连接的糖基化减少增加了 NPC1 疾病在小鼠中的严重程度,并提出了这样的假设,即参与天冬酰胺连接的糖基化的基因突变可能导致 NPC1 患者疾病严重程度的进展。为了对此进行检查,我们分析了 111 名 NPC1 患者的两个与多发性硬化症相关的 SNPs;然而,我们没有发现与 NPC1 表型严重程度相关的关联。